First Trust Advisors
PDLI

First Trust Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

First Trust Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-128,338
Closed -$317K – 2553
2017
Q2 		$317K Sell
128,338
-7,909
-6% -$18.2K ﹤0.01% 2192
2017
Q1 		$309K Sell
136,247
-49,363
-27% -$109K ﹤0.01% 2211
2016
Q4 		$393K Buy
185,610
+95,628
+106% +$267K ﹤0.01% 2203
2016
Q3 		$301K Buy
+89,982
New +$286K ﹤0.01% 2139
2016
Q1 		– Sell
-1,150,124
Closed -$4.07M – 2388
2015
Q4 		$4.07M Sell
1,150,124
-20,252,443
-95% -$84.8M 0.01% 1049
2015
Q3 		$108M Buy
21,402,567
+3,865,774
+22% +$22.2M 0.31% 61
2015
Q2 		$113M Buy
17,536,793
+3,424,045
+24% +$22.9M 0.29% 71
2015
Q1 		$99.3M Buy
14,112,748
+5,421,150
+62% +$39.3M 0.29% 63
2014
Q4 		$67M Buy
8,691,598
+7,591,489
+690% +$60.1M 0.23% 87
2014
Q3 		$8.22M Sell
1,100,109
-75,415
-6% -$700K 0.03% 786
2014
Q2 		$11.4M Buy
1,175,524
+148,107
+14% +$1.32M 0.05% 605
2014
Q1 		$8.54M Sell
1,027,417
-215,955
-17% -$1.85M 0.04% 748
2013
Q4 		$10.5M Buy
1,243,372
+64,660
+5% +$545K 0.05% 597
2013
Q3 		$9.39M Buy
1,178,712
+39,488
+3% +$317K 0.05% 563
2013
Q2 		$8.79M Buy
+1,139,224
New +$8.88M 0.06% 498

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Trust Advisors's PDLI Position: Q3 2017 in Review

First Trust Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q3 2017, closing a stake of 128,338 shares — an estimated $317K sold.

First Trust Advisors first reported a position in PDLI in Q2 2013 and held it in 15 quarters. The position peaked at $113M in Q2 2015. 186 funds tracked by Wall St. Rank hold PDLI as of Q3 2017.

  • First Trust Advisors reported no remaining PDL BioPharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • First Trust Advisors sold 128,338 PDL BioPharma, Inc. shares in Q3 2017, an estimated $317K.
  • First Trust Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 15 quarters.
  • First Trust Advisors's PDL BioPharma, Inc. position peaked at $113M in Q2 2015.
  • 186 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2017.

Based on First Trust Advisors's 13F filing for Q3 2017, filed 24 Oct 2017.